Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction.

Shiau BW, Hsu WH, Kuo CC, Huang PY, Tsai YW, Wu JY, Liu TH, Chuang MH, Lai CC

DOI: 10.1038/s43856-026-01759-4
Published: 2026 Jun 29
Container: Communications medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43856-026-01759-4,
  title = {Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction.},
  author = {Shiau BW and Hsu WH and Kuo CC and Huang PY and Tsai YW and Wu JY and Liu TH and Chuang MH and Lai CC},
  year = {2026},
  journal = {Communications medicine},
  doi = {10.1038/s43856-026-01759-4},
  url = {https://doi.org/10.1038/s43856-026-01759-4}
}

RIS

TY  - JOUR
TI  - Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction.
AU  - Shiau BW
AU  - Hsu WH
AU  - Kuo CC
AU  - Huang PY
AU  - Tsai YW
AU  - Wu JY
AU  - Liu TH
AU  - Chuang MH
AU  - Lai CC
PY  - 2026
JO  - Communications medicine
DO  - 10.1038/s43856-026-01759-4
UR  - https://doi.org/10.1038/s43856-026-01759-4
ER  -

APA

BW, S., WH, H., CC, K., PY, H., YW, T., JY, W., TH, L., MH, C., & CC, L. (2026). Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction.. Communications medicine. https://doi.org/10.1038/s43856-026-01759-4

Source records

pubmed · retrieved 2026-09-27T09:23:34.633Z